Results 221 to 230 of about 51,767 (241)

Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis. [PDF]

Eur J Haematol
Stalker M, Garfall A, Cohen A, Vogl DT, Djulbegovic M, Susanibar-Adaniya S, Stadtmauer E, Megherea O, Waxman AJ.   +8 more
europepmc   +1 more source

Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health

Journal of Internal Medicine, Volume 299, Issue 1, Page 20-43, January 2026.
Abstract Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline. Although amyloid‐β and tau pathologies remain central to our understanding of AD, growing evidence suggests that disrupted lipid metabolism and impaired bioenergetics are closely linked to these hallmark features. Genetic, lipidomic
Silvia Maioli, Ivan Nalvarte, Maria Ankarcrona, Marianne Schultzberg, Kristen L. Zuloaga, Julen Goikolea, Pieter Jelle Visser, Bart De Strooper, Bengt Winblad, Paola Pizzo, Pete A. Williams, Patricia Rodriguez‐Rodriguez, Luana Naia   +12 more
wiley   +1 more source

Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes

Journal of Internal Medicine, Volume 299, Issue 1, Page 95-108, January 2026.
Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a heterogenous clinical picture. This study aimed to link genetic SLE predisposition with relevant clinical manifestations. Method Datasets best corresponding to the 11 American College of Rheumatology 1982 (ACR‐82) classification criteria for SLE in a large, public ...
Sarah Reid, Johanna K. Sandling, Pascal Pucholt, Ahmed Sayadi, Martina Frodlund, Karoline Lerang, Iva Gunnarsson, Andreas Jönsen, Ann‐Christine Syvänen, Øyvind Molberg, Solbritt Rantapää‐Dahlqvist, Anna Rudin, Christopher Sjöwall, Elisabet Svenungsson, Anders A. Bengtsson, Lars Rönnblom, Dag Leonard   +16 more
wiley   +1 more source

Autologous stem cell transplantation in AL amyloidosis: Muddy waters. [PDF]

Blood Rev
Hagen P, D'Souza A.
europepmc   +1 more source

Different Sequential Renal Involvement in a Patient With HIV and Hepatitis C: From HIV‐ or Leishmaniasis‐Related Collapsing Glomerulosclerosis to Direct‐Acting Antivirals’ Renal Amyloidosis

Case Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
The paradigm of renal involvement in HIV patients has changed in recent years, from HIV‐associated nephropathy to nephroangiosclerosis, due to the increased survival of these patients and their comorbidities. Some of these are leishmaniasis and hepatitis C and their treatments, especially direct‐acting antivirals, which may induce reconstitution of the
María Adoración Martín Gómez, Mercedes Caba Molina, Elisa Fernández Fuertes, Inés Pérez-Camacho, Ana Belén Lozano Serrano, Rafael del Pozo Álvarez, Rajib Chowdhury   +6 more
wiley   +1 more source

AL amyloidosis with elevated peripheral blood cell counts - A frequent association with liver involvement. A single-center retrospective study. [PDF]

Leuk Res Rep
Ziarkiewicz M, Szczygieł J, Legatowicz-Koprowska M, Drozd-Sokołowska J, Boguradzki P, Jamroziak K, Basak G.   +6 more
europepmc   +1 more source

A Case Report of Non‐Neutralizing Acquired Factor V Inhibitor Mimicking Deficiency: Diagnostic Challenges and Therapeutic Implications

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Acquired Factor V (FV) deficiency due to inhibitors is a rare coagulopathy that presents significant diagnostic and therapeutic challenges. We report the case of an 81‐year‐old male with persistent gross hematuria and severe coagulopathy, marked by prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and critically low FV ...
Shreyas Kalantri, Pranali Pachika, Shiva Balasubramanian, Bayan Alquran, Morgan McCoy, Vivek Sharma, Andrew Song   +6 more
wiley   +1 more source

Immune Therapies in AL Amyloidosis-A Glimpse to the Future. [PDF]

Cancers (Basel)
Haran A, Vaxman I, Gatt ME, Lebel E.
europepmc   +1 more source

Current management of non‐amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes

British Journal of Haematology, Volume 208, Issue 1, Page 329-332, January 2026.
Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi, Hira Shaikh, Beth Faiman, Faiz Anwer, Sandra Mazzoni, Diana Basali, Jack Khouri, Christy Samaras, Jason Valent, Shahzad Raza, Louis Williams   +14 more
wiley   +1 more source